Laws
Treaties
Judgments
Browse By Jurisdiction
Patented Medicines (Notice of Compliance) Regulations, Canada
Back
Superseded Text
Go to latest Version in WIPO Lex
Year of Version
1993
Dates
Adopted:
March 12, 1993
Type of Text
Implementing Rules/Regulations
Subject Matter
Patents (Inventions),
IP Regulatory Body,
Industrial Property
Notes
The notification by Canada to the WTO under Article 63.2 of TRIPS states:
The Patented Medicines (Notice of Compliance) Regulations 'allows an innovator to bring an application to prohibit the granting of marketing approval (Notice of Compliance) for a drug, that relies upon the earlier approval of a related drug until all the relevant product and use patents (but not process patents) pertaining to the earlier approved medicine have expired.'
Available Texts
Main text(s)
Main text(s)
French
Règlement sur les médicaments brevetés (avis de conformité)
PDF
HTML
English
Patented Medicines (Notice of Compliance) Regulations
PDF
HTML
Legislation
Is superseded by (3 text(s))
Is superseded by (3 text(s))
WIPO Lex No.
CA027